• ELRA · OTCQB
  • VHGI · OTCQB
  • VVTV · NASDAQ
  • AAMRQ · NYSE
  • STKO · OTCQB
  • ISIM · OTC
  • MNAP · OTCQB
  • BCCI · OTC
  • VHGI · OTCQB
  • DSKX · OTCQB
  • Special Biotech Report on Wound Management Technologies (OTCBB:WNDM)

    Written by: Dana Salvo

    Bookmark and Share

    The Stock Wizards Featured Profile

    TV Website for CellerateRX (Brought to you by TV Goods)

    WNDM

    Wound Management Technologies, Inc

    Current Price - 0.615 Cents

    www.WmgTech.com WNDM

    Wound Management Technologies, Inc. (WNDM) is a rapidly growing provider of advanced biotechnology products. The company’s unique, patented CellerateRX® products address the very large and growing advanced wound care markets. The U.S. market in 2007 was $3.0B and is projected to double by 2013 (source BCC research).

    With an amazing product like CellerateRX® and a market cap of only approx. 23 million, The Stock Wizards is very surprised to see WNDM trading down at these levels.

    Here is a list of some very impressive features of CellerateRX®:

    *No prescription required.

    *Reduces pain.

    *Cost effective.

    *Reimbursed by Medicare in most States.

    *Cleared by the FDA as a medical device for use on all acute and chronic wounds except for 3rd degree burns.

    *Available in powder and gel.

    *Biocompatible, biodegradable.

    *Easy to use - prepare the wound bed, apply product, cover it up.

    *Used to treat diabetic wounds. The diabetic and long term care markets are a major focus due to the prevalence of diabetic and pressure ulcers.

    “The clinical results we have observed have validated the science beyond the product. I would highly recommend CellerateRX® to any conscientious wound care provider”Desmond P Bell, Jr. DPM, President & Co-Founder, Save a Leg, Safe a Life Foundation.

    Core Revenue Stream: Wound Care Innovations, LLC (WCI)
    Wound Care Innovations is a wholly owned subsidiary of WNDM and brings a unique and dynamic mix of expertise, products, procedures and service to the wound care arena. WCI was formed with the sole purpose of bringing CellerateRX® and activated collagen-based products to the $3B US wound care market. Since then, WCI has expanded marketing internationally.

    Evidence-based Clinical Studies
    CellerateRX® has current and on-going evidenced-based studies and other clinical peer reviewed publications. These can be found on the CellerateRX website.

    Sales & Marketing Channel Expansion
    Having completed evidence-based studies, the company developed its sales channel plan and engaged sales & marketing executives in April 2010.

    Strategic Biotechnology Acquisitions, Products
    In the fall of 2009 WMND acquired a patent for resorbable bone wax and bone void filler products in a subsidiary: Resorbable Orthopedic Products, LLC. The worldwide bio materials market for these types of products is over $1.4 Billion. WNDM anticipates our new products will be cleared by the FDA and ready for marketing in the 1H 2011.

    eHealth Technology Acquisition
    In February 2010, WNDM acquired secure data and messaging provider Secure eHealth, LLC. Secure eHealth has a complete suite of scalable products for secure intelligent healthcare communication, collaboration, storage and transport.

    WNDM
    Market Cap: approx. $23.15M (03/01/11)
    Recent Price: $0.615 (03/01/11)
    Shares Outstanding: 37,661,225 (3Q 2010)
    Estimated Float: 3.3M
    Fiscal Year: December 31

    2011 Projections
    Revenue: $6 M
    Net Income: $1.4 M

    StockBlaster.com

    Discloser, Disclaimers: http://thestockwizards.net/about/disclaimer/

    TheStockWizards.net is not a registered investment advisers or broker/dealer. TheStockWizards.net makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. TheStockWizards.net is compliant with The Can Spam Act of 2003.

    Forward-Looking Statement: This advertisiment profile includes “forward-looking statements” within the meaning of the federal securities laws, commonly identified by such terms as “believes,” “looking ahead,” “anticipates,” “estimates” and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company’s projections and expectations are disclosed in the Company’s filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TheStockWizards.net strongly urges you to conduct a complete due diligence of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. TheStockWizards.net does not offer such advice or analysis, and TheStockWizards.net urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

    PLEASE NOTE:  TheStockWizards.net has been compensated twenty thousand shares of WNDM from a third party (Rusbar Financial) for a three month advertising campaign and forty thousand (40,000) restricted shares. Details are listed under disclaimers and disclosures. Any compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. When compensated by a third party, please be fully aware that the third party may have shares and may liquidate it, which may negatively affect the market. When TheStockWizards.net receives free trading shares as compensation for a profiled company, TheStockWizards.net may sell part or all of any such shares during the period in which TheStockWizards.net is performing such services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies.  In addition, there may be members on this board that receive compensation for particular stock awareness without telling members, so please always use your own buy and sell signals based on your own decisions.  Any recent increase in volume or increase in stock price may be due to The StockWizards.com representatives buying. The Stock Wizards intend to sell shares received as compensation for providing Company Background Information, sending opt-in emails, posting charts, videos, site moderation, consulting etc. We do not give price targets in any of our written or recorded material. TheStockWizards.net will not advise as to when we decide to sell and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.  Please do your own research and make your own investment decisions. Always remember that TheStockWizards.net is not an analyst and we do not employ or contract any analysts. In preparing profile publication, TheStockWizards.net have relied upon information supplied by its customers and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in these websites. Rather, investors should use the information contained in these websites as a starting point for doing additional independent research on the featured companies. Investing in securities such as the ones mentioned on our website, in email, or consulted for are for high-risk tolerant individuals only and not the general public.

    Release of Liability: Through use of this website viewing or using you agree to hold TheStockWizards.net, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources, which we believe to be reliable, but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TheStockWizards.net affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. TheStockWizards.net encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and TheStockWizards.net makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. In preparing this publication, TheStockWizards.net has relied upon information supplied by its customers, and press releases, which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies.

    March 2, 2011 @ 2:47 am Trackback URL Posted in Profiles and tagged with , , , , , .